Influence of Treatment With the HMG-CoA-Reductase Inhibitor Fluvastatin on Erectile Function in Patients With Cardiovascular Risk-Factors and Erectile Dysfunction.
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 29 Aug 2016
At a glance
- Drugs Fluvastatin (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- 06 Jul 2012 New source identified and integrated (German Clinical Trials Register: DRKS00003988).
- 12 Feb 2009 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 21 Oct 2006 New trial record.